Evaxion A (EVAX) Cash from Investing Activities (2020 - 2022)
Evaxion A (EVAX) reported Cash from Investing Activities of -$77000.0 for Q2 2022, up 90.63% on a YoY basis from -$40391.8 in Q2 2021, and up 51.57% quarter-over-quarter from -$159000.0 in Q1 2022.
Evaxion A (EVAX) Cash from Investing Activities (2020 - 2022) Analysis & Trends
Evaxion A has reported Cash from Investing Activities for 3 years, with the latest figure at -$77000.0 in Q2 2022.
- For the quarter ending Q2 2022, Cash from Investing Activities rose 90.63% year-over-year to -$77000.0; the trailing twelve-month figure through Jun 2022 stood at -$2.2 million (down 57.25% YoY), and the FY2025 full-year result was -$14000.0, down 366.67% from the prior year.
- Cash from Investing Activities for Q2 2022 stood at -$77000.0, up from -$159000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was -$77000.0 in Q2 2022, with the low at -$1.2 million in Q3 2021.
- Historically, Cash from Investing Activities has averaged -$359500.0 across 3 years, with a median of -$145000.0 in 2020.
- Annual changes were most pronounced in 2021 — Cash from Investing Activities slumped 780.15% — and 2022, when it surged 90.63%.
- Evaxion A's Cash from Investing Activities stood at -$131000.0 in 2020, then tumbled by 780.15% to -$1.2 million in 2021, then jumped by 93.32% to -$77000.0 in 2022.
- The last three Cash from Investing Activities figures came in at -$77000.0 (Q2 2022), -$159000.0 (Q1 2022), and -$1.2 million (Q3 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.89 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 638.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -431.90 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 579,519.10 |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | -428.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -77,000.00 |
| Jun 30, 2022 | -77,000.00 |
| Mar 31, 2022 | -159,000.00 |
| Mar 31, 2022 | -159,000.00 |
| Sep 30, 2021 | -1.15 Mn |
| Sep 30, 2021 | -1.15 Mn |
| Jun 30, 2021 | -822,000.00 |
| Jun 30, 2021 | -822,000.00 |
| Mar 31, 2021 | -327,000.00 |
| Mar 31, 2021 | -327,000.00 |
| Sep 30, 2020 | -131,000.00 |
| Sep 30, 2020 | -131,000.00 |
| Jun 30, 2020 | -126,000.00 |
| Jun 30, 2020 | -126,000.00 |
| Mar 31, 2020 | -81,000.00 |
| Mar 31, 2020 | -81,000.00 |